Abstracts tagged "palindromic rheumatism"

Abstract Number: 2131 • 2014 ACR/ARHP Annual Meeting
the Impact of Patient-Reported Flares on Radiographic Progression in Rheumatoid Arthritis Patients with Low-Disease Activity: Secondary Analyses from a Randomized Trial
Dorota Kuettel¹, Jette Primdahl^2,3,4,5, Lykke Midtbøll Ørnbjerg⁶, Hans Christian Horn⁷, Robin Christensen⁸ and Kim Hørslev-Petersen⁹, ¹Rheumatological, King Christian X's Hospital for Rheumatic Diseases, Graasten, Denmark, ²Rheumatology, King Christian X's Hospital for Rheumatic Diseases, Graasten, Denmark, ³Institute for Regional Health Research, University of Southern Denmark, Graasten, Denmark, ⁴Hospital of Southern Jutland, Soenderborg, Denmark, ⁵Danbio Registry, Glostrup, Denmark, ⁶Copenhagen Center for Arthritis Reasearch, Center for Rheumatology and Spine diseases, Glostrup Hospital, Copenhagen, Denmark, ⁷Internal Medicine/Rheumatology, Odense University Hospital, Odense, Denmark, ⁸Rheumatology, MSU, The Parker Institute, Copenhagen University Hospital, Frederiksberg, Denmark, ⁹Research Unit at King Christian X Hospital for Rheumatic Diseases, Graasten, Denmark
Background/Purpose Flares, potentially disabling and disease worsening even when a patient is in low disease activity, are common features in patients with rheumatoid arthritis (RA)…
Abstract Number: 2293 • 2013 ACR/ARHP Annual Meeting
Anti-Citrullinated Peptide/Protein Antibody Specificities and Subclinical Synovitis In Palindromic Rheumatism: Towards a Better Understanding Of The Relationship With Rheumatoid Arthritis
Sonia Cabrera-Villalba¹, Julio Ramirez¹, Georgina Salvador², Virginia Ruiz-Esquide³, M. Victoria Hernández⁴, José Inciarte⁵, Celia Saura¹, J. D. Cañete¹ and Raimon Sanmarti³, ¹Rheumatology, Hospital Clinic, Barcelona, Spain, ²Rheumatology Unit., Hospital Mutua de Terrassa. Barcelona, Barcelona, Spain, ³Arthritis Unit. Rheumatology Department, Hospital Clínic of Barcelona, Barcelona, Spain, ⁴Arthritis Unit, Department of Rheumatology, Hospital Clinic, Barcelona, Barcelona, Spain, ⁵Arthritis Unit. Rheumatology Service, Hospital Clinic of Barcelona, Barcelona, Spain
Background/Purpose: Palindromic rheumatism (PR) may evolve to rheumatoid arthritis (RA), especially in anti-citrullinated peptide/protein antibody (ACPA) positive patients, although many do not evolve to RA…

All abstracts accepted to ACR Convergence are under embargo once the ACR has notified presenters of their abstract’s acceptance, and cannot be presented at other meetings after this time. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until November 7 at 10:00 AM ET. Journalists with access to embargoed information also cannot release articles before this time.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Permissions and Reprints

For information about abstract permissions and reprints, see ACR Convergence permissions and reprint policies.